株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

PCR市場:qPCR、dPCR、シングルプレックス、マルチプレックス市場:エグゼクティブ・コンサルタントガイド、カスタマイズ予測と分析(2020~2024年)

PCR Markets: Forecasts for qPCR, dPCR, Singleplex & Multiplex Markets with Executive and Consultant Guides, Including Customized Forecasting and Analysis 2020 to 2024

発行 Howe Sound Research 商品コード 854116
出版日 ページ情報 英文 276 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=109.82円で換算しております。
Back to Top
PCR市場:qPCR、dPCR、シングルプレックス、マルチプレックス市場:エグゼクティブ・コンサルタントガイド、カスタマイズ予測と分析(2020~2024年) PCR Markets: Forecasts for qPCR, dPCR, Singleplex & Multiplex Markets with Executive and Consultant Guides, Including Customized Forecasting and Analysis 2020 to 2024
出版日: 2019年06月03日 ページ情報: 英文 276 Pages
概要

シングルプレックス検査はもう古いのか、日常的癌検査が現実のものとなるのか、かかりつけ医や在宅にて診断が可能となるのか、そしてデジタルPCRが新たな試験所の基準となるのでしょうか。

当レポートでは、世界のPCR市場について調査し、市場の現況と将来動向、成長の機会、地域別動向、市場に参入する企業のプロファイルについてまとめています。

市場ガイド

第1章 イントロダクションと市場の定義

  • PCR技術とは
  • PCR:ニューホライズン
  • 市場の定義
  • 調査方法
  • 米国医療市場と試験所検査:展望

第2章 PCR技術のガイド

  • PCR
  • コンセプト
  • 応用
  • PCR:長所と短所
  • 様々な種類のPCR

第3章 業界概要

  • 市場参入企業

第4章 市場動向

  • 成長促進因子
  • 成長阻害因子
  • 治療技術開発

第5章 PCR近年の発展

第6章 PCR企業プロファイル

第7章 PCR市場

  • 国別市場概要

第8章 世界のPCR市場:用途別

  • 概要
  • 臨床マルチプレックス
  • 臨床シングルプレックス
  • 研究
  • 法医学
  • その他

第9章 技術別市場

  • 概要
  • qPCR
  • dPCR
  • その他

付録

図表

Table of Tables

  • TABLE 1: List of Cancers by Mortality
  • TABLE 2: Lab Spending 2014 to 2024
  • TABLE 3: Market Players by Type
  • TABLE 4: Five Factors Driving Growth
  • TABLE 5: Three Factors Limiting Growth
  • TABLE 6: GLOBAL PCR MARKET BY REGION
  • TABLE 7: GLOBAL MARKET BY APPLICATION
  • TABLE 8: PCR CLINICAL MULTIPLEX BY COUNTRY
  • TABLE 9: PCR CLINICAL SINGLEPLEX BY COUNTRY
  • TABLE 10: PCR RESEARCH BY COUNTRY
  • TABLE 11: PCR FORENSIC BY COUNTRY
  • TABLE 12: PCR OTHER BY COUNTRY
  • TABLE 13: GLOBAL MARKET BY TECHNOLOGY
  • TABLE 14: QPCR BY COUNTRY
  • TABLE 15: DPCR BY COUNTRY
  • TABLE 16: OTHER PCR BY COUNTRY
  • TABLE 17: 2018 Clinical Lab Fee Schedule

Table of Figures

  • FIGURE 1: Cancer Death Rates - USA, CDC
  • FIGURE 2: Clinical Lab Spending 2014 to 2024
  • FIGURE 3: The PCR Process
  • FIGURE 4: Creation of Sample Droplets for Digital PCR
  • FIGURE 5: Comparing Syndromic and Targeted Testing
  • FIGURE 6: Comparing The New Diagnostics and Traditional Testing
  • FIGURE 7: Growth rates of DiagnosticTechnologies
  • FIGURE 8: 2018 Global Market Density Chart
  • FIGURE 9: PCR Market by Application - 2019 vs. 2024
  • FIGURE 10: PCR MARKET 2019
  • FIGURE 11: PCR MARKET 2024
  • FIGURE 12: APPLICATION SHARE BY YEAR
  • FIGURE 13: PCR CLINICAL MULTIPLEX TESTING GROWTH
  • FIGURE 14: PCR CLINICAL SINGLEPLEX TESTING GROWTH
  • FIGURE 15: PCR RESEARCH GROWTH
  • FIGURE 16: PCR FORENSIC GROWTH
  • FIGURE 17: PCR OTHER GROWTH
  • FIGURE 18: PCR MARKET BY TECHNOLOGY - 2019 VS. 2024
  • FIGURE 19: PCR MARKET 2019
  • FIGURE 20: PCR MARKET 2024
  • FIGURE 21: TECHNOLOGY SHARE BY YEAR
  • FIGURE 22: QPCR GROWTH
  • FIGURE 23: DPCR GROWTH
  • FIGURE 24: OTHER PCR GROWTH
目次

“PCR Markets Enter Digital Age Poised to Dominate Diagnostic Markets...“

OVERVIEW:

Are singleplex tests going to be obsolete? Will routine cancer screening become a reality? Will diagnostics move into the Physician's Office or even the Home? Will digital PCR become the new lab standard?

Our facts and support = Your success.

The report forecasts the market size out to 2024 with the only analysis available that breaks out Singleplex and Multiplex testing markets. PCR has proved itself in the market. And the new generation of PCR, digital PCR promises to keep that success going. New levels of sensitivity have implications for Liquid Biopsy and Cancer Screening markets. Lowering costs, improving outcomes and even helping in the battle against Anti Microbial Resistance. Learn about this market including the issues and outlooks. The two key trends of Point of Care Testing and Molecular Diagnostics are merging with spectacular success.

Our research makes you the expert in your organization. Get our research team working for you by ordering this comprehensive report. Your credit card order sends the report to your inbox instantly. Check all your licensing options but don't worry, your order is available as a credit if you wish to upgrade to a wider license. We wrote this report and we are ready, by phone or email, to help you use it. As always, assistance, and additional specific data, is provided without additional charges.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.

ABOUT THE LEAD AUTHOR:

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes:

  • B.Sc. (Chemistry) University of BC
  • M.B.A. (Finance and Policy) University of BC
  • Market Research Seminar - Burke Institute
  • Finance for Senior Executives - Harvard Business School

Table of Contents

i. Market Guides

  • iA. Situation Analysis
  • iB. Guide for Executives and Marketing Staff
  • iC. Guide for Investment Analysts and Management Consultants

1. Introduction and Market Definition

  • 1.1. What are PCR Technologies?
  • 1.2. PCR - New Horizons
    • 1.2.1. PCR and Syndromic Testing
  • 1.3. Market Definition
    • 1.3.1. Market Size
    • 1.3.2. Currency
    • 1.3.3. Years
  • 1.4. Methodology
    • 1.4.1. Authors
    • 1.4.2. Sources
  • 1.5. U.S. Medical Market and laboratory Testing - Perspective
    • 1.4.1. U.S. Medicare Expenditures for Laboratory Testing

2. PCR - Guide to PCR Technologies

  • 2.0. PCR
  • 2.1. Concepts
    • 2.1.1. Method
  • 2.2. Applications
    • 2.2.1. Finding Specific DNA
    • 2.2.2. Measuring DNA
    • 2.2.3. Medical and diagnostic applications
      • 2.2.3.1. Carrier, prenatal and tissue typing
      • 2.2.3.2. Cancer Diagnosis and Management
      • 2.2.3.3. Infectious disease - New Levels of Accuracy and Sensitivity
      • 2.2.3.4. Forensic applications
      • 2.2.3.5. Science and Research
  • 2.3. PCR - Advantages and Disadvantages
  • 2.4. Different Types of PCR
    • 2.4.1. Simple Changes
      • 2.4.1.1. Multiplex-PCR
      • 2.4.1.2. VNTR PCR
      • 2.4.1.3. Asymmetric PCR
      • 2.4.1.4. Long PCR
      • 2.4.1.5. Nested PCR
      • 2.4.1.6. Quantitative PCR
      • 2.4.1.7. Hot-start PCR
      • 2.4.1.8. Touchdown PCR
      • 2.4.1.9. Assembly PCR
      • 2.4.1.10. Colony PCR
      • 2.4.1.11. Suicide PCR
      • 2.4.1.12. Cold PCR
    • 2.4.2. Digital PCR
      • 2.4.2.1. Droplet Digital PCR
      • 2.4.2.2. Comparison between dPCR and Real-Time PCR (qPCR)
      • 2.4.2.3. Digital PCR in Use
      • 2.4.2.4. Digital PCR Commercial History
    • 2.4.3. Isothermal PCR

3. Industry Overview

  • 3.1. Players in a Dynamic Market
    • 3.1.1. Academic Research Lab
    • 3.1.2. Diagnostic Test Developer
    • 3.1.3. Genomic Instrumentation Supplier
      • 3.1.3.1. Cell Separation and Viewing Instrumentation Supplier
    • 3.1.4. Pharmaceutical/Reagent Supplier
    • 3.1.5. Independent Testing Lab
    • 3.1.6. Public National/regional lab
    • 3.1.7. Hospital lab
    • 3.1.8. Physician Lab
    • 3.1.9. Audit Body
    • 3.1.10. Certification Body

4. Market Trends

  • 4.1. Factors Driving Growth
    • 4.1.1. A New Standard
    • 4.1.2. Down the Curve We Go
    • 4.1.3. Multiplexing
    • 4.1.4. Syndromic Diagnostics Looks Unstoppable
    • 4.1.5. The Genetic Blizzard
  • 4.2. Factors Limiting Growth
    • 4.2.1. The Cost Curve
    • 4.2.2. The Other Guys
    • 4.2.3. Systemic Roadblocks
  • 4.3. Diagnostic Technology Development
    • 4.3.1. The Instrumentation Curve
    • 4.3.2. Shifting Role of Diagnostics
    • 4.3.3. Diagnostics Moves Out of the Lab
      • 4.3.3.1. What About Imaging?
    • 4.3.4. Disruption Looms
    • 4.3.5. The Next Five Years

5. PCR Recent Developments

  • 5.1. Recent Developments - Importance and How to Use This Section
    • 5.1.1. Importance of These Developments
    • 5.1.2. How to Use This Section
      • QIAGEN Plans for Next-Generation Digital PCR Systems
      • Bioneer HIV-1 Dx Kit Gets Korea FDA Approval
      • New PCR Technology: Transfer-PCR (tPCR) Applications
      • NimaGen Licenses PCR Tech from Salisbury NHS Foundation Trust
      • Natera Applies Massively Multiplexed PCR to Kidney Transplants
      • Paragon Genomics, MGI Tech Form Distribution Alliance
      • Synlab Pharma, Biotype Collaborate on Gastrointestinal, Endometrial Cancers
      • Qiagen, NeuMoDx Ink Partnership, Merger Agreement
      • Bruker to Acquire Majority in Hain Lifescience GmbH
      • Curetis to Cut 30 Percent of Workforce as Part of Strategic Restructuring
      • Cancer Early Detection Firm Ark Launches With $40M Series A Investment
      • PredictImmune Wins £100K Grant for Study of IBD Prognostic
      • Biocartis, AstraZeneca Partner on European Lung Cancer Biomarker Study
      • llumina Ventures Leads €16M Series A Investment in Digital PCR Firm Stilla Technologies
      • Bio-Rad Wins USDA Food Safety Testing Contract
      • Luminex, XCR Diagnostics Sign Nucleic Acid Amplification Tech Licensing Deal

6. Profiles of Key PCR Companies

  • Abbott Diagnostics (Alere)
  • Accelerate Diagnostics
  • Agilent
  • Alveo Technologies
  • Applied BioCode
  • Atlas Genetics
  • Aus Diagnostics
  • BD Diagnostics
  • Biocartis
  • BioFire Diagnostics
  • bioMérieux
  • Bioneer
  • Bio-Rad Laboratories
  • Bosch Healthcare Solutions GmbH
  • Bruker
  • Cepheid
  • Curetis
  • Diagenode Diagnostics
  • Diasorin
  • Fluidigm
  • Fusion Genomics.
  • GenePOC Diagnostics
  • GenMark Dx
  • Hologic
  • Invetech
  • Janssen Diagnostics
  • Karius
  • Lexigene
  • Luminex
  • Mesa Biotech
  • Mobidiag
  • Nanomix
  • Panagene
  • Precipio
  • Primerdesign
  • Prominex
  • Qiagen (Statdx)
  • Quantumdx
  • Roche Molecular Diagnostics
  • Seegene
  • Stilla Technologies
  • Siemens Healthineers (Fast Track Diagnostics)
  • SkylineDx
  • T2 Biosystems
  • Thermo Fisher
  • Veramarx
  • XCR Diagnostics

7. The PCR Markets

  • 7.1. PCR - Global Market Overview by Country
    • 7.1.1. Table - Global Market by Country
    • 7.1.2. Chart - Global Market by Country

8. Global PCR Markets - By Application

  • 8.1. Global Market by Application - Overview
    • 8.1.1. Table - Global Market by Application
    • 8.1.2. Chart - Global Market by Application - 2019/2024 Comparison
    • 8.1.3. Chart - Global Market by Application - 2019
    • 8.1.4. Chart - Global Market by Application -2024
    • 8.1.4. Chart - Global Market by Application - Share by Year
  • 8.2. PCR Clinical Multiplex
    • 8.2.1. Table PCR Clinical Multiplex Testing - by Country
    • 8.2.2. Chart - PCR Clinical Multiplex Testing Growth
  • 8.3. PCR Clinical Singleplex
    • 8.3.1. Table PCR Clinical Singleplex Testing - by Country
    • 8.3.2. Chart - PCR Clinical Singleplex Testing Growth
  • 8.4. PCR Research
    • 8.4.1. Table PCR Research - by Country
    • 8.4.2. Chart - PCR Research Growth
  • 8.5. PCR Forensic
    • 8.5.1. Table PCR Forensic - by Country
    • 8.5.2. Chart - PCR Forensic Growth
  • 8.6. PCR Other
    • 8.6.1. Table PCR Other - by Country
    • 8.6.2. Chart - PCR Other Growth

9. Global PCR Markets - By Technology

  • 9.1. Global Market by Technology - Overview
    • 9.1.1. Table - Global Market by Technology
    • 9.1.2. Chart - Global Market by Technology - 2019/2024 Comparison
    • 9.1.3. Chart - Global Market by Technology - 2019
    • 9.1.4. Chart - Global Market by Technology -2024
    • 9.1.4. Chart - Global Market by Technology - Share by Year
  • 9.2. qPCR
    • 9.2.1. Table qPCR - by Country
    • 9.2.2. Chart - qPCR Growth
  • 9.3. dPCR
    • 9.3.1. Table dPCR - by Country
    • 9.3.2. Chart - dPCR Growth
  • 9.4. Other PCR
    • 9.4.1. Table Other PCR - by Country
    • 9.4.2. Chart - Other PCR Growth

Appendices

  • I. United States Medicare System: 2018 Clinical Laboratory Fees Schedule - National Limit and Midpoint
  • II. FDA Approved Microbial Tests
Back to Top